| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |